DUBLIN--(BUSINESS WIRE)--The "Innovations in Chemotherapy Personalization, Cell Transplants, Multi-drug Resistance Studies, and Adult Stem Cell Regeneration" report has been added to ResearchAndMarkets.com's offering.
The Genetic Technology TechVision Opportunity Engine (TOE) presents trends across chemotherapy personalization, cell transplantation, multi-drug resistance studies, and adult stem cell regeneration. The corresponding clinical trials scenario related to monoclonal antibody drugs for autoimmune diseases is also depicted.
Key Topics Covered:
1. Recent Advances in Chemotherapy Personalization, Cell Transplants, Multi-drug Resistance Studies and Adult Stem Cell Regeneration
Chemotherapy Genetic Interaction Map for Personalized Treatment
Pancreatic Cell Transplant Capable of Vascularization
Decoding Acinetobacter Baumannii's Multi-drug Resistance
Adult Stem Cell Regeneration by Fasting
2. Clinical Trial Analysis and Key Contacts
Clinical Trial Analysis of Monoclonal Antibody Drugs for Autoimmune Diseases
Key Contacts
For more information about this report visit https://www.researchandmarkets.com/research/dwt685/innovations_in?w=4
